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targeting the rRNA 18s gene (1, 2), were adopted for their optimal
performance. This study presents and discusses the results of the
use of RT-PCRs in conjunction with ELISA (VMRD, USA) and IFAT
(Fuller Laboratories, USA) that were used to analyse 274 horse
sera. For comparison of results, PCRwas used as reference method
since sequencing of derived amplicons conﬁrmed them as spe-
ciﬁc. The B. caballi RT-PCR detected 14 positive samples, none
conﬁrmed in ELISA, while the IFAT had a sensitivity (Se) of 50% (7/
14) and a speciﬁcity (Sp) of 87.7 % (228/260). The T. equi detected
137 positive samples with the ELISA showing a Se of 67.2% (92/
137) and an Sp of 83.2% (114/137) and the IFAT, a Se of 86.1% (118/
137) and an Sp of 81% (111/137). For both parasites, the IFAT
presented a limited major sensitivity when compared to the
ELISA. Results for B. caballi are preliminary as number of samples
recruited is limited. In particular, for T. equi the serological tests
showed a high agreement and a relatively high speciﬁcity. An
initial evaluation of the correlation between the PCR result and
clinical status of the animal was carried out deﬁning as cases
those presenting an EP acute form based on temperature >38C
and at least one of the following signs, jaundice, anaemia, and
petechial haemorrhages together with a PCR positive result. Of
the PCR positive horses for B. caballi and T. equi, only 28.7% and
19.7% respectively were deﬁned as cases, possibly due to parasite
persistence beyond the acute form. Seropositve results of PCR
negative samples could be due to sterilization of infected horses,
occurring spontaneously or following treatment with a longer
persistence of antibodies as usually occurs in most infections. An
additional value of the use of quantitative PCR is that treatment
efﬁcacy may be monitored especially in view of the side effects
this possess. This study demonstrates that the simultaneous use
of PCR with serological tests increases the diagnostic probability
to deﬁne the sanitary state for EP for the purposes stated above
and underlines the need for revision of the prescribed diagnostic
tests for trade that should include more sensitive methods.
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Eastern and Venezuelan equine encephalitis cause signiﬁcant
disease in both horses and humans.
Effective equine diagnostics (passive surveillance of cases with
compatible clinical syndromes) can serve as advance warning for
human illnesses. In Central and South America, there are serious
difﬁculties in obtaining quality reagents for EEE and VEE di-
agnostics (per Dr. Alfonso Clavijo, Pan American Health Organi-
zation (PAHO), personal communication). Utilizing the genome of
Sindbis virus (SINV), a relatively nonpathogenic human alphavi-
rus, as a vector, a chimeric SIND/VEE virus expressing all of the
structural proteins of the VEE TC-83 vaccine strain has been
developed (Paessler 2003,Wang 2007). The nonstructural protein
genes and cis-acting RNA genome elements from wild-type SINV
strain AR339, and the structural protein genes from either North
American EEEV strain FL93- 939, or from the naturally murine-
attenuated SA strain BeAr436087, are included in the SIND/EEE
chimeras. In collaboration with PAHO, MIDA, and the InstitutoGORGAS, the National Veterinary Services Laboratories have ac-
quired these Sindbis/Alphavirus chimeras from Dr. Scott Weaver
of the University of Texas Medical Branch to validate proposed
diagnostic assays. Validation of diagnostic tests that can be per-
formed at biosafety level-2 will be beneﬁcial for use in both the
United States and in other countries. Chimeric virus propagation
was performed. Direct comparison of the SIND/EEE chimera to
wild-type EEE virus was performed using OIE approved protocols
for EEE IgM Enzyme-linked Immunosorbent Assay (ELISA) and
Plaque Reduction Neutralization Test (PRNT). Testing was per-
formed utilizing sera from naturally infected horses, determined
to be positive by previous diagnostic testing. With the goal of
developing inexpensive, easily performed diagnostics, the chi-
meras were tested without inactivation, using the methods pre-
viously mentioned. Antigen at a 1:10 dilution provided
consistently valid results with varying concentrations of both
conjugate and serum. Additional testing of inactivated chimeras
will also be performed. In addition to the increased safety to
humans who are conducting the diagnostic testing, proposed use
of chimeric strains in diagnostics will improve the ability of North,
South and Central American laboratories to easily and inexpen-
sively detect infection in animals, thereby leading to improved
prevention of infection in both humans and other equids.
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Equine herpesvirus 5 (EHV-5) infection has recently been asso-
ciated with equine multinodular pulmonary ﬁbrosis in horses. To
more completely understand EHV-5 pathogenesis and determine
viral and host contributions, further in vivo and in vitro studies are
needed. However, current techniques are unable to rapidly, spe-
ciﬁcally, and quantitatively characterize EHV-5 infection. The aim
of this project was to develop a TaqMan real-time PCR assay to
quantify EHV-5 in clinical and cell culture samples, and use this
test to describe viral replication over time in primary equine
respiratory epithelial cells (EREC)s. Primers and a probe were
designed to target gene E11 of EHV-5 for TaqMan real-time PCR.
Speciﬁcity was veriﬁed by testing multiple isolates of EHV-5, as
well as DNA from other equine herpesviruses. A plasmid con-
taining the target DNA was generated to create a standard curve
and quantify viral copy number. TaqMan real-time PCR was per-
formed on DNA isolated from clinical samples. In addition, ERECs
were inoculated with EHV-5, and cells and supernatants were
collected daily for 12 days following inoculation and TaqMan real-
time PCR was performed to asses EHV-5 infection and replication.
